Cargando…

Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence

BACKGROUND: Poor adherence to antihypertensive treatment remains a clinical challenge worldwide. The objectives of this study were to assess the adherence level to antihypertensive treatment and to identify its associated factors in a sample of hypertensive patients in Lebanon and Jordan. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhaddad, Imad A, Hamoui, Omar, Hammoudeh, Ayman, Mallat, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089866/
https://www.ncbi.nlm.nih.gov/pubmed/27822055
http://dx.doi.org/10.2147/VHRM.S105921
_version_ 1782464308811137024
author Alhaddad, Imad A
Hamoui, Omar
Hammoudeh, Ayman
Mallat, Samir
author_facet Alhaddad, Imad A
Hamoui, Omar
Hammoudeh, Ayman
Mallat, Samir
author_sort Alhaddad, Imad A
collection PubMed
description BACKGROUND: Poor adherence to antihypertensive treatment remains a clinical challenge worldwide. The objectives of this study were to assess the adherence level to antihypertensive treatment and to identify its associated factors in a sample of hypertensive patients in Lebanon and Jordan. METHODS: We conducted an observational study between May 2011 and September 2012. A total of 1,470 eligible hypertensive patients were enrolled in our study and followed up for a period of 6 months. Data were collected regarding sociodemographic, health behavior, and hypertension-related characteristics. The adherence to treatment and the quality of life were self-reported using the Morisky, Green & Levine Scale and the Hypertension Quality of Life Questionnaire. RESULTS: Our results revealed that 55.9 % of the patients were adherent to their antihypertensive medication. Older age was associated with better adherence, whereas being divorced or widowed, having a poorer quality of life, and being classified as having stage 1 or 2 hypertension at the end of the study were all associated with poorer adherence. CONCLUSION: Efforts should be exerted on all levels in order to increase the adherence to anti-hypertensive treatment through the implementation of educational campaigns.
format Online
Article
Text
id pubmed-5089866
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50898662016-11-07 Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence Alhaddad, Imad A Hamoui, Omar Hammoudeh, Ayman Mallat, Samir Vasc Health Risk Manag Original Research BACKGROUND: Poor adherence to antihypertensive treatment remains a clinical challenge worldwide. The objectives of this study were to assess the adherence level to antihypertensive treatment and to identify its associated factors in a sample of hypertensive patients in Lebanon and Jordan. METHODS: We conducted an observational study between May 2011 and September 2012. A total of 1,470 eligible hypertensive patients were enrolled in our study and followed up for a period of 6 months. Data were collected regarding sociodemographic, health behavior, and hypertension-related characteristics. The adherence to treatment and the quality of life were self-reported using the Morisky, Green & Levine Scale and the Hypertension Quality of Life Questionnaire. RESULTS: Our results revealed that 55.9 % of the patients were adherent to their antihypertensive medication. Older age was associated with better adherence, whereas being divorced or widowed, having a poorer quality of life, and being classified as having stage 1 or 2 hypertension at the end of the study were all associated with poorer adherence. CONCLUSION: Efforts should be exerted on all levels in order to increase the adherence to anti-hypertensive treatment through the implementation of educational campaigns. Dove Medical Press 2016-10-27 /pmc/articles/PMC5089866/ /pubmed/27822055 http://dx.doi.org/10.2147/VHRM.S105921 Text en © 2016 Alhaddad et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Alhaddad, Imad A
Hamoui, Omar
Hammoudeh, Ayman
Mallat, Samir
Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence
title Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence
title_full Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence
title_fullStr Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence
title_full_unstemmed Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence
title_short Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence
title_sort treatment adherence and quality of life in patients on antihypertensive medications in a middle eastern population: adherence
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089866/
https://www.ncbi.nlm.nih.gov/pubmed/27822055
http://dx.doi.org/10.2147/VHRM.S105921
work_keys_str_mv AT alhaddadimada treatmentadherenceandqualityoflifeinpatientsonantihypertensivemedicationsinamiddleeasternpopulationadherence
AT hamouiomar treatmentadherenceandqualityoflifeinpatientsonantihypertensivemedicationsinamiddleeasternpopulationadherence
AT hammoudehayman treatmentadherenceandqualityoflifeinpatientsonantihypertensivemedicationsinamiddleeasternpopulationadherence
AT mallatsamir treatmentadherenceandqualityoflifeinpatientsonantihypertensivemedicationsinamiddleeasternpopulationadherence